Data as of Nov 25
| -0.01 / -0.12%|
The 6 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 11.54, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +42.25% increase from the last price of 8.11.
The current consensus among 6 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.